Genetics Generation Advancement Corp.
Genetics Generation Advancement Corp. provides genetic testing and informatics services in Taiwan. The company offers testing services, including pre-implantation, prenatal, newborn medical examination, health management, reproductive medicine testing, obstetrics and gynecology testing, and neonatology and pediatrics testing, as well as gastroenterology, hepatology, oncology, and medical research… Read more
Market Cap & Net Worth: Genetics Generation Advancement Corp. (4160)
Genetics Generation Advancement Corp. (TWO:4160) has a market capitalization of $12.89K (NT$426.42K) as of March 18, 2026. Listed on the TWO stock exchange, this Taiwan-based company holds position #44544 globally and #1975 in its home market, demonstrating a -4.17% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Genetics Generation Advancement Corp.'s stock price NT$47.15 by its total outstanding shares 9044 (9.04K).
Genetics Generation Advancement Corp. Market Cap History: 2025 to 2026
Genetics Generation Advancement Corp.'s market capitalization history from 2025 to 2026. Data shows growth from $13.61K to $12.89K (0.00% CAGR).
Genetics Generation Advancement Corp. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Genetics Generation Advancement Corp.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 4160 by Market Capitalization
Companies near Genetics Generation Advancement Corp. in the global market cap rankings as of March 18, 2026.
Key companies related to Genetics Generation Advancement Corp. by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #90 globally with a market cap of $177.20 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #151 globally with a market cap of $122.79 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #466 globally with a market cap of $46.38 Billion USD.
- Lonza Group Ltd (PINK:LZAGF): Ranked #511 globally with a market cap of $41.73 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #90 | Thermo Fisher Scientific Inc | NYSE:TMO | $177.20 Billion | $472.71 |
| #151 | Danaher Corporation | NYSE:DHR | $122.79 Billion | $195.21 |
| #466 | IDEXX Laboratories Inc | NASDAQ:IDXX | $46.38 Billion | $586.98 |
| #511 | Lonza Group Ltd | PINK:LZAGF | $41.73 Billion | $596.13 |
Genetics Generation Advancement Corp. Historical Marketcap From 2025 to 2026
Between 2025 and today, Genetics Generation Advancement Corp.'s market cap moved from $13.61K to $ 12.89K, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$12.89K | -5.32% |
| 2025 | NT$13.61K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Genetics Generation Advancement Corp. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $12.89K USD |
| MoneyControl | $12.89K USD |
| MarketWatch | $12.89K USD |
| marketcap.company | $12.89K USD |
| Reuters | $12.89K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.